Transcode Therapeutics, Inc. (RNAZ) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2020: 4.64M2021: 12.90M2022: 16.2K2023: 19.0K2024: 36.8K2025: 917.0K917.0K
2020Shares Outstanding (shares)2025
Fiscal YearShares OutstandingChange YoY
2025917.0K+2394.9%
202436.8K+93.3%
202319.0K+17.2%
202216.2K-99.9%
202112.90M+178.3%
20204.64M